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Sexual Dysfunction
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Purpose: We evaluated the effects of surgery for rectal cancer on postoperative voiding 
and sexual function over the course of time.
Materials and Methods: Data from 28 patients who underwent autonomic nerve pre-
serving rectal cancer surgery were retrospectively analyzed. Operations were per-
formed between October 2005 and July 2007 and all patients were followed-up for more 
than 3 years. Preoperatively, all patients underwent urodynamic studies including uro-
flowmetry, and filled out the International Prostate Symptom Score (IPSS). The evalua-
tion of sexual function consisted of Erectile Function domain score in International 
Index of Erectile Function (IIEF-EFD) and Ejaculation domain score in Male Sexual 
Health Questionnaire (MSHQ-EjD). Data from uroflowmetry and questionnaires were 
examined.
Results: At 3 years postoperatively the prostate volume was similar to the preoperative 
value (p=0.727). There were no statistically significant postoperative changes in the 
average maximum flow rate (15.9 ml/s vs. 16.2 ml/s, p=0.637) and post-void residual 
urine volume (34.7 ml vs. 36.8 ml, p=0.809). No statistically significant differences were 
observed in the IPSS (13.2 vs. 12.2, p=0.374). However, although pelvic autonomic 
nerve preservation have been performed, a significant proportion of rectal cancer pa-
tients suffer from sexual dysfunction and the average of IIEF-EFD and MSHQ-EjD 
scores was decreased postoperatively until 3 years (25.1 vs. 16.1 and 28.3 vs. 14.2 re-
spectively, p＜0.001).
Conclusions: Voiding function was not affected after autonomic nerve-preserving rectal 
cancer surgery, however sexual function was significantly aggravated. We recommend 
that the baseline genitourinary function should be evaluated before the treatment for 
male rectal cancer patients, and penile rehabilitation is necessary for their quality of 
life after treatment.
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INTRODUCTION
Voiding and sexual dysfunction are well-known complica-
tions after rectal resection for carcinoma, the main cause 
of which is injury to the autonomic nerves in the pelvis: the 
sacral splanchnic (parasympathetic) nerves and hypo-
gastric (sympathetic) nerves [1-5]. These injuries may re-
sult from blunt pelvic dissection or undefined cutting dur-
ing mobilization of the rectum.
　As described by Heald in the 1980s, total mesorectal ex-
cision (TME) was introduced as the standard operative pro-
cedure for rectal cancer in combination with autonomic 
nerve preservation (ANP). Compared with conventional 
rectal cancer surgery, TME with ANP has been reported 
to reduce the incidence of complications of voiding and sex-
ual function [3,6,7]. Despite the dramatic improvements in 
the surgical procedure for rectal cancer, the reported in-
cidence of postoperative voiding issues and sexual dysfunc-Korean J Urol 2010;51:858-862
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TABLE 1. Patient characteristics 
Parameter
No. of patients 28
Mean age at surgery (yr) 58.2 (41-72)
Mean body mass index (kg/m
2) 23.2 (18.3-27.6)
Tumor size (cm) 5.2 (1.1-10.0)
UICC stage (n)
　16
　25
　31 5
　42
Operation type (n)
　LAR 22
　APR 6
Comorbidity (n)
　Diabetes 7
　Hypertension 8
Smoking (n)
　Nonsmoker 18
　Current and ex-smoker 10
Sexual activity (n)
　Active 21
　Not active 7
Neoadjuvant chemoradiotherapy 11
Adjuvant chemotherapy 17
UICC: Union International Contre le Cancer, n: No. of patients,
LAR: low anterior resection, APR: abdominoperineal resection
tion still ranges from 0% to 12% and from 20% to 50%, re-
spectively [1,3,4,8,9].
　Because of the early detection and advances in the treat-
ment of rectal cancer, survival rates have improved, and 
it is expected that an increasing number of patients will be 
living with its sequelae. Therefore, quality of life after 
treatment is regarded as an important outcome in addition 
to the traditional endpoints, such as survival and recurrence. 
However, only a few studies have been published to date 
presenting an objective evaluation of voiding and sexual 
function after rectal resection. Most studies have assessed 
postoperative functional outcome at only one time point, 
rather than longitudinally.
　This study aimed to evaluate the changes in male voiding 
capability and sexual function within a consecutive series 
of patients who underwent autonomic-nerve-preserving 
surgery for rectal cancer at our institution. 
MATERIALS AND METHODS
Of the total of 78 men who underwent TME with ANP for 
rectal cancer at the Korea Cancer Center Hospital between 
October 2005 and July 2007, 45 patients were evaluated 
preoperatively for genitourinary function. We retrospec-
tively analyzed the data of 28 men who were followed up 
for more than 3 years. 
　All of the operations were performed by two surgeons 
(DYH and SMM), both being experts in technique and colo-
rectal surgery. TME was performed according to the princi-
ples described by Heald et al [7], and the pelvic autonomic 
nerves, including the hypogastric nerve and pelvic splan-
chnic plexus (nervi erigentes), were preserved in all pa-
tients [10,11].
　Preoperatively, all patients underwent urodynamic stu-
dies including uroflowmetry and filled out the Interna-
tional Prostate Symptom Score (IPSS). Voiding function 
was measured objectively with maximum flow rate (Qmax) 
and postvoid residual urine volume (PVR). Prostate vol-
umes, measured by computed tomography (CT) before and 
after the operation, were compared. 
　We used the erectile function domain score on the 
International Index of Erectile Function (IIEF-EFD) and 
the ejaculation domain on the Male Sexual Health Que-
stionnaire (MSHQ-EjD), both of which have been widely 
used, to evaluate sexual function. Erectile dysfunction 
(ED) severity was classified into 3 categories: normal, 26 
or more; mild to moderate, 17 to 25; and moderate to severe, 
16 or less. Patient characteristics, including age, tumor 
stage, tumor size, and type of operation, were recorded. The 
patients were followed after surgery by use of uroflow-
metry and the aforementioned questionnaires.
　Patients with recurrent or metastatic disease, a history 
of urinary tract surgery, prior rectal surgery, or no pre-
operative urodynamic assessment were excluded.
　Statistical analysis was performed with SPSS ver. 12.0 
(SPSS Inc., Chicago, IL, USA), using the paired Student's 
t-test and Wilcoxon signed-rank test. Data were considered 
to be statistically significant when the p-value was less 
than 0.05.
RESULTS
1. Patient characteristics
The characteristics of the patients are summarized in 
Table 1. The mean follow-up duration was 45.4 months 
(range, 37-53 months). The patients’ mean age was 58.2 
years (range, 41-72 years) and their mean body mass index 
(BMI) was 23.2 kg/m
2 (range, 18.3-27.6 kg/m
2).
　Tumor stage was determined on the basis of the Union 
International Contre le Cancer (UICC) classification. 
Sphincter-preserving rectal resection was performed in 22 
patients, and the remainder received abdominoperineal 
resection (APR). There were 21 sexually active patients in-
cluding 3 men who had moderate to severe ED. Eleven pa-
tients had received preoperative chemoradiotherapy. 
2. Voiding function
Preoperatively, all patients showed normal detrusor pres-
sure and seven patients showed an obstructive pattern in 
the urodynamic study. No patients demonstrated detrusor 
overactivity, and the mean functional bladder capacity was 
276.3 ml. The mean PVR was 34.7 ml and only one patient 
had a PVR over 100 ml. 
　The results of the urinary function assessment over the 
3-year study period are presented in Table 2. At 3 years Korean J Urol 2010;51:858-862
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TABLE 3. Postoperative changes in sexual parameters
p-value vs. 
preoperation
No. of patients 18
IIEF-EFD
　Preoperation 25.1±2.6
　3 mo 18.0±8.7 0.001
　1 yr 16.9±7.5 ＜0.001
　3 yr 16.1±8.2 ＜0.001
MSHQ-EjD
　Preoperation 28.3±5.2
　3 mo 17.4±14.0 0.001
　1 yr 14.7±9.3 0.001
　3 yr 14.2±10.3 ＜0.001
IIEF-EFD: erectile function domain score in the International 
Index of Erectile Function, MSHQ-EjD: ejaculation domain score
in the Male Sexual Health Questionnaire
TABLE 4. Postoperative changes in erectile dysfunction severity
Preoperation
Postoperation
3 months 1 year 3 years
Erectile function 
　Normal (26 or more) 56 11 17 11
　Mild to moderate (17-25) 44 50 44 39
　Moderate to severe (16 or less)   0 39 39 50
Values are presented as percentage.
TABLE 2. Postoperative changes in voiding parameters
p-value vs. 
preoperation
No. of patients 28
Prostate volume (ml)
　Preoperation 27.6±8.3
　3 mo N/A
　1 yr N/A
　3 yr 27.9±10.0 0.727
Qmax (ml/s)
　Preoperation 15.9±6.7
　3 mo 14.7±7.2 0.566
　1 yr 14.8±6.8 0.455
　3 yr 16.2±6.1 0.637
PVR (ml)
　Preoperation 34.7±16.5
　3 mo 37.5±12.4 0.795
　1 yr 37.0±16.9 0.844
　3 yr 36.8±13.6 0.809
IPSS
　Preoperation 13.2±8.6
　3 mo 11.4±5.0 0.332
　1 yr 11.8±5.8 0.292
　3 yr 12.2±6.3 0.374
Qmax: maximum flow rate, PVR: postvoid residual urine volume,
IPSS: International Prostate Symptom Score
postoperatively, the prostate volume was similar to the 
preoperative value (p＞0.05). There were no statistically 
significant postoperative changes in the average Qmax 
(15.9 ml/s vs. 16.2 ml/s, p=0.637) or PVR (34.7 ml vs. 36.8 
ml, p=0.809). No statistically significant differences were 
observed in the IPSS (13.2 vs. 12.2, p=0.374). In eight pa-
tients (29%), the IPSS was worse at 3 months than at 
baseline. However, at 1 year after surgery, the scores had 
returned to the baseline values. 
　Six patients presented with mild postoperative voiding 
dysfunction that required alpha-blocker medication. 
Medical therapy was sufficient to achieve normal voiding 
and no patients needed catheterization during the fol-
low-up period.
3. Sexual function
Preoperatively, 10 of the patients were specified as having 
moderate to severe ED, including 7 men who were not sex-
ually active. We evaluated the 18 sexually active men who 
had no moderate to severe ED. Their mean age was 54.6 
years (range, 41-68 years). Changes in sexual parameters 
are summarized in Table 3. The average IIEF-EFD and 
MSHQ-EjD scores had significantly decreased 3 months 
postoperatively (p＜0.001). This difference was still sig-
nificant at 1 and 3 years. Reductions in the IIEF-EFD and 
MSHQ-EjD scores were observed in 11 (61%) and 13 (72%) 
men, respectively. The number of patients who belonged 
to the moderate to severe ED group gradually increased 
(Table 4). Eight men experienced a complete loss of erectile 
function and stated that their sexual life became worse af-
ter surgery. 
DISCUSSION
Postoperative voiding and sexual dysfunctions frequently 
develop after pelvic surgery. These complications result 
from thermal damage, ischemic injury, nerve stretching, 
and the local inflammatory effects to the hypogastric nerve 
and the sacral splanchnic plexus during pelvic dissection. 
Injury to the sympathetic supply results in detrusor insta-
bility and ejaculatory difficulties, whereas injury to the 
parasympathetic supply results in poor detrusor contrac-
tion and ED [1,7,10,12].
　Even though comparisons between studies are difficult Korean J Urol 2010;51:858-862
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TABLE 5. Studies on voiding and sexual function after autonomic-nerve-preserving rectal cancer surgery
Author Year
No. of 
patients 
Voiding 
dysfunction (%)
Erectile 
dysfunction (%)
Ejaculatory 
dysfunction (%)
Kim et al [1] 2002 68 26 25 38
Pocard et al [2] 2002 9 0 44 11
Nesbakken et al [3] 2000 49 13 28 43
Maas et al [5] 1998 47 28 11 42
Sterk et al [13] 2005 49 23 38 0.7
Ameda et al [18] 2005 52 30 88 83
due to differing exclusion criteria and outcome measures, 
widely varying rates of voiding and sexual dysfunction af-
ter rectal surgery have been reported in the literature 
(Table 5). During rectal surgery, the ANP procedure causes 
less impairment of genitourinary function [8,13,14]. The 
functional benefits of ANP were confirmed in previous 
studies that evaluated the impact of ANP on rectal cancer 
by use of questionnaires [3,5,6]. Since the awareness of 
ANP, voiding complications appear to have diminished to 
a level of 0% to 4% [15]. For example, Nesbakken et al and 
colleagues reported that, when comparing results before 
and 3 months after the operation in 49 patients, rectal can-
cer surgery with pelvic autonomic nerve preservation 
showed no significant changes in voiding capacity [3]. 
Similarly, our study showed no significant complications 
related to voiding. Based on our data, rectal cancer surgery 
with ANP showed excellent preservation of voiding func-
tion; even 3 years after surgery, the results of the IPSS did 
not change significantly.
　The transient decrease in Qmax might be explained by 
postoperative inflammatory changes in the perivesical tis-
sues and the possible resolution of partial nerve damage 
with time, resulting in improvement and even complete re-
covery [13].
　In contrast with the preservation of voiding function, 
sexual dysfunction remains a significant problem after rec-
tal cancer surgery. Previous studies suggested that partial 
preservation of the pelvic autonomic nerves was sufficient 
to attain eventual functional recovery in voiding function 
[16,17]. The main cause of postoperative sexual dysfunc-
tion is intraoperative injury to the neurovascular bundles; 
partial dissection of the pelvic plexus can also affect sexual 
function [18].
　Results of studies on male sexual function after rectal 
cancer surgery show impotence rates varying from 20% to 
50% [3,9,13]. Ameda et al reported that postoperative ED 
was a serious complication, even in complete nerve preser-
vation [18]. Hendren et al also reported that a high rate of 
sexual dysfunction is detected after rectal cancer excision, 
despite the use of nerve-preserving techniques [19].
　The incidence of ED depends on the extent of resection, 
which may be reduced with nerve preservation [7,11]. In 
this study, all patients underwent bilateral ANP. The re-
sults of our study show that a significant proportion of rec-
tal cancer patients suffer from sexual dysfunction after 
surgery. Overall, eight men (29%) experienced a complete 
loss of erectile function. These patients did not improve 
throughout the follow-up period. Therefore, it is likely that 
the crucial cause of postoperative sexual dysfunction is un-
recognized nerve injury rather than neurapraxia. The in-
timate anatomic relationship of the superior hypogastric 
nerve, the bilateral inferior hypogastric plexus, and the bi-
lateral cavernosal nerves to the rectum and prostate ex-
plains their possible risk of injury. The nerve damage 
might have occurred after the nerve to the bladder had 
branched off in the deep narrow pelvis where precise dis-
section may be more difficult. The high incidence of sexual 
dysfunction may be due to the vulnerability to nerve 
damage.
　Although many factors influence postoperative sexual 
dysfunction, we could not determine a statistically sig-
nificant relationship between sexual dysfunction and 
well-known adverse factors such as patient’s age, stage, 
type of operation, smoking, chemoradiotherapy, and co-
morbidities because of the relatively small number of pa-
tients in this study.
　With the relatively small number of patients and the ret-
rospective nature of this study, our results are bound to be 
underpowered. Because the study population was “rectal 
cancer patients who are free of recurrence,” the results may 
not be generalizable to all patients undergoing rectal can-
cer surgery. Despite the limitations of the data, however, 
the strength of our study is its long-term assessment with 
preoperative evaluation.
　Preservation and maintenance of sexual function are 
guaranteed to be challenges to urologists in the future. In 
order to improve patient's quality of life, urologists will 
need to make an effort to detect patients who suffer from 
sexual dysfunction and treat them by cooperating and col-
laborating with surgeons. Also, patients need to be prop-
erly informed about possible adverse effects connected to 
the operation and how these adverse effects can be treated 
if they arise.
　Although no standardized regimen exists, post-prosta-
tectomy rehabilitation of sexual function or ED prophy-
laxis has become a common practice among urologists [20]. 
Interestingly, Lindsey et al reported that erectile function 
was satisfactorily improved by use of sildenafil (Viagra) on-
ly in 79% of male patients with ED after rectal excision for 
either rectal cancer or inflammatory bowel disease [21]. 
Likewise, baseline measurement and enthusiastic penile 
rehabilitation after rectal cancer surgery must be con-Korean J Urol 2010;51:858-862
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sidered.
CONCLUSIONS
Voiding dysfunction after rectal cancer surgery and radio-
therapy can be avoided in most patients by the preservation 
of pelvic autonomic nerves. However, although pelvic auto-
nomic nerve preservation has been performed, a sig-
nificant proportion of these surgical rectal cancer patients 
will still suffer from sexual dysfunction after surgery.
　Larger prospective randomized comparative studies are 
necessary to confirm our results, which were limited be-
cause of the small number of patients. Urologists should 
investigate sexual function before surgery to generate 
meaningful outcomes for counseling patients before and af-
ter treatment, and penile rehabilitative treatment after 
rectal cancer surgery must be considered. 
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